Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125931051 | 12593105 | 1 | I | 20160329 | 20160726 | 20160726 | PER | US-ABBVIE-16P-163-1594726-00 | ABBVIE | 0.00 | F | Y | 0.00000 | 20160726 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125931051 | 12593105 | 1 | PS | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | U | 21402 | ||||||||||
| 125931051 | 12593105 | 2 | SS | JAKAFI | RUXOLITINIB | 1 | Oral | U | AC1857P | 0 | 10 | MG | BID | ||||||
| 125931051 | 12593105 | 3 | C | URSODEOXYCHOLIC ACID | URSODIOL | 1 | Unknown | 0 | |||||||||||
| 125931051 | 12593105 | 4 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | 50000 UT | 0 | ||||||||||
| 125931051 | 12593105 | 5 | C | SERTRALINE | SERTRALINE HYDROCHLORIDE | 1 | Unknown | 0 | |||||||||||
| 125931051 | 12593105 | 6 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | Unknown | 0 | |||||||||||
| 125931051 | 12593105 | 7 | C | ACYCLOVIR. | ACYCLOVIR | 1 | Unknown | 0 | |||||||||||
| 125931051 | 12593105 | 8 | C | PARACETAMOL | ACETAMINOPHEN | 1 | Unknown | 0 | |||||||||||
| 125931051 | 12593105 | 9 | C | TYLENOL PM | ACETAMINOPHENDIPHENHYDRAMINE | 1 | Unknown | 0 | |||||||||||
| 125931051 | 12593105 | 10 | C | OPTIVE | CARBOXYMETHYLCELLULOSE SODIUMGLYCERIN | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125931051 | 12593105 | 1 | Product used for unknown indication |
| 125931051 | 12593105 | 2 | Myelofibrosis |
| 125931051 | 12593105 | 3 | Product used for unknown indication |
| 125931051 | 12593105 | 4 | Product used for unknown indication |
| 125931051 | 12593105 | 5 | Product used for unknown indication |
| 125931051 | 12593105 | 6 | Product used for unknown indication |
| 125931051 | 12593105 | 7 | Product used for unknown indication |
| 125931051 | 12593105 | 8 | Product used for unknown indication |
| 125931051 | 12593105 | 9 | Product used for unknown indication |
| 125931051 | 12593105 | 10 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125931051 | 12593105 | Blood thyroid stimulating hormone decreased | |
| 125931051 | 12593105 | Bone density decreased | |
| 125931051 | 12593105 | Drug interaction | |
| 125931051 | 12593105 | Herpes zoster | |
| 125931051 | 12593105 | Vitamin D decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |